TRAIL Promotes VSMC Proliferation and Neointima Formation in a FGF-2-, Sp1 Phosphorylation-, and NFκB-Dependent Manner

被引:72
作者
Chan, Jeffrey [1 ]
Prado-Lourenco, Leonel [1 ]
Khachigian, Levon M. [1 ]
Bennett, Martin R. [2 ]
Di Bartolo, Belinda A. [1 ]
Kavurma, Mary M. [1 ]
机构
[1] Univ New S Wales, Ctr Vasc Res, Sydney, NSW 2052, Australia
[2] Univ Cambridge, Addenbrookes Hosp, Div Cardiovasc Med, Cambridge CB2 2QQ, England
基金
英国医学研究理事会;
关键词
TRAIL; VSMC proliferation; injury; transcriptional regulation; APOPTOSIS-INDUCING LIGAND; SMOOTH-MUSCLE-CELLS; ACTIVATED PROTEIN-KINASES; ENDOTHELIAL-CELLS; GENE-EXPRESSION; RECEPTOR; INDUCTION; INJURY; OSTEOPROTEGERIN; IDENTIFICATION;
D O I
10.1161/CIRCRESAHA.109.206029
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rationale: TRAIL ( tumor necrosis factor-related apoptosis-inducing ligand) is well reported as an inducer of apoptosis in tumor models; however, its role and function in vivo in atherosclerosis and vascular injury has not been established. Objective: We sought to study the function of TRAIL in cardiovascular pathology and its regulation in vivo. Methods and Results: Here, we show that TRAIL was upregulated in medial vascular smooth muscle cells (VSMCs) 24 hours following perivascular cuff placement around femoral arteries of mice. We also show that TRAIL mRNA and promoter activity was induced in VSMCs following in vitro mechanical injury. Intimal thickening 15 days after cuff placement was reduced 2- to 3-fold in TRAIL(-/-) compared to wild-type mice and was reversible by administration of recombinant TRAIL. Additionally, reduced VSMC proliferation was observed in injured arteries of TRAIL(-/-) mice. Fibroblast growth factor (FGF)-2, a potent growth factor released following vascular injury, was also reduced in arteries of TRAIL(-/-) mice, and VSMCs isolated from these animals did not respond to FGF-2 in vitro. Injury and FGF-2 regulated TRAIL transcriptional activity via 2 specificity protein (Sp) 1 elements in the proximal TRAIL promoter, a binding site also shared by nuclear factor (NF)kappa B. Mutational studies confirmed a role for Sp1 in injury- and FGF-2-inducible TRAIL transcription. Furthermore, increased NF kappa B expression after injury transactivated the TRAIL promoter. Interestingly, following mechanical injury, Sp1 phosphorylation (Thr453) and an increase in the physical interaction of p-Sp1(Thr453) with NF kappa B was observed. Conclusions: We conclude that TRAIL induction involves FGF-2, Sp1-phosphorylation and NF kappa B and that TRAIL promotes VSMC proliferation and neointima formation after arterial injury. (Circ Res. 2010; 106: 1061-1071.)
引用
收藏
页码:1061 / 1071
页数:11
相关论文
共 34 条
[1]  
Akishita M, 2000, PHYSIOL GENOMICS, V2, P13
[2]   TRAIL-induced apoptosis in human vascular endothelium is regulated by phosphatidylinositol 3-kinase/Akt through the short form of cellular FLIP and Bcl-2 [J].
Alladina, SJ ;
Song, JH ;
Davidge, ST ;
Hao, CH ;
Easton, AS .
JOURNAL OF VASCULAR RESEARCH, 2005, 42 (04) :337-347
[3]   Fibroblast growth factor-2 represses platelet-derived growth factor receptor-α (PDGFR-α) transcription via ERK1/2-dependent Sp1 phosphorylation and an atypical cis-acting element in the proximal PDGFR-α promoter [J].
Bonello, MR ;
Khachigian, LM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (04) :2377-2382
[4]   Insulin down-regulates TRAIL expression in vascular smooth muscle cells both in vivo and in vitro [J].
Corallini, Federica ;
Celeghini, Claudio ;
Rizzardi, Clara ;
Pandolfi, Assunta ;
Di Silvestre, Sara ;
Vaccarezza, Mauro ;
Zauli, Giorgio .
JOURNAL OF CELLULAR PHYSIOLOGY, 2007, 212 (01) :89-95
[5]   Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice [J].
Cretney, E ;
Takeda, K ;
Yagita, H ;
Glaccum, M ;
Peschon, JJ ;
Smyth, MJ .
JOURNAL OF IMMUNOLOGY, 2002, 168 (03) :1356-1361
[6]   Blockade of vascular smooth muscle cell proliferation and intimal thickening after balloon injury by the sulfated oligosaccharide PI-88 - Phosphomannopentaose sulfate directly binds FGF-2, blocks cellular signaling, and inhibits proliferation [J].
Francis, DJ ;
Parish, CR ;
McGarry, M ;
Santiago, FS ;
Lowe, HC ;
Brown, KJ ;
Bingley, JA ;
Hayward, IP ;
Cowden, WB ;
Campbell, JH ;
Campbell, GR ;
Chesterman, CN ;
Khachigian, LM .
CIRCULATION RESEARCH, 2003, 92 (08) :E70-E77
[7]   TRAIL expression in vascular smooth muscle [J].
Gochuico, BR ;
Zhang, J ;
Ma, BY ;
Marshak-Rothstein, A ;
Fine, A .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2000, 278 (05) :L1045-L1050
[8]   Expression, regulation and function of trail in atherosclerosis [J].
Kavurma, Mary M. ;
Bennett, Martin R. .
BIOCHEMICAL PHARMACOLOGY, 2008, 75 (07) :1441-1450
[9]   TRAIL stimulates proliferation of vascular smooth muscle cells via activation of NF-κB and induction of insulin-like growth factor-1 receptor [J].
Kavurma, Mary M. ;
Schoppet, Michael ;
Bobryshev, Yuri V. ;
Khachigian, Levon M. ;
Bennett, Martin R. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (12) :7754-7762
[10]   Sp1 phosphorylation regulates apoptosis via extracellular FsasL-Fas engagement [J].
Kavurma, MM ;
Santiago, FS ;
Bonfoco, E ;
Khachigian, LM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (07) :4964-4971